Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 9, pp. 1910-1919
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 8, 2019
- Revision received April 23, 2019
- Accepted June 7, 2019
- Published first June 12, 2019.
Article Versions
- Previous version (June 12, 2019 - 07:01).
- Previous version (August 8, 2019 - 06:13).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Yi Zhu1,2,
- George A. Howard3,
- Keith Pittman3,
- Christi Boykin1,2,
- Laura E. Herring4,5,
- Emily M. Wilkerson4,5,
- Kathryn Verbanac3, and
- Qun Lu1,2,*
- 1Department of Anatomy and Cell Biology, The Brody School of Medicine at East Carolina University, Greenville, North Carolina.
- 2The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Diseases Research, The Brody School of Medicine at East Carolina University, Greenville, North Carolina.
- 3Department of Surgery, The Brody School of Medicine at East Carolina University, Greenville, North Carolina.
- 4Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- 5Michael Hooker UNC Proteomics Core, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- ↵*Corresponding Author:
Qun Lu, East Carolina University, The Brody School of Medicine, 7N72 Brody Sciences Building, 600 Moye Boulevard, Greenville, NC 27834. Phone: 252-744-2844; Fax: 252-744-2850; E-mail: luq{at}ecu.edu
September 2019
Volume 17, Issue 9
Volume 17, Issue 9
Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA–NF-κB
Jump to section
Advertisement